Clinical trial Recruiting at 1 site Observational Ages 18 to 40

Mobility and strength before, and three and six months after, hip arthroscopy for femoroacetabular impingement

Official title: Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months

Run by University of Liege · NCT07472400 · Data updated 2026-11-12

This project will see how mobility, strength, and functional task performance change before surgery and at three and six months after hip arthroscopy in people ages 18–40 with femoroacetabular impingement, comparing the operated hip to the other hip and to healthy volunteers.

Quick facts

Study typeObservational
Ages18 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Liege
Academic / other
Locations1 site (Sart Tilman, Liège)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedMay 5, 2026
Trial IDNCT07472400 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–40 with symptomatic, imaging-confirmed femoroacetabular impingement who are scheduled for hip arthroscopy, without prior hip surgery or recent muscle injuries, are ideal candidates.

Probably not a fit

People with prior hip surgery, hip dysplasia, rheumatic or pediatric hip disease, recent injuries to assessed muscles, or those outside the 18–40 age range are unlikely to be appropriate or to benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a controlled observational protocol that compares the pathological hip of patients undergoing hip arthroscopy to their contralateral healthy hip and to an external healthy control group. Participants will complete mobility and strength measures, functional performance tests, and questionnaires before surgery and again at three and six months postoperatively. The assessments are performed in-person at the Blanc Gravier sports centers associated with the University of Liège. Data will be used to map recovery trajectories and identify persistent deficits at key rehabilitation time points.

Why it matters

Potential benefit: If successful, the results could help clinicians target rehabilitation to speed recovery and reduce persistent functional deficits after hip arthroscopy.

How similar studies have gone: Previous observational work has reported persistent strength and mobility deficits after hip arthroscopy, so this approach builds on existing evidence but focuses on direct comparison with the contralateral hip and healthy controls over three and six months.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects with femoroacetabular impingement syndrome, with corresponding clinical symptoms and signs, as well as validation by imaging
* Subjects who have already consulted a surgeon specializing in hip arthroscopic surgery and whose surgery is planned to treat femoroacetabular impingement syndrome
* Subjects aged between 18 and 40

Exclusion Criteria:

* History of rheumatic disease, dysplasia or pediatric disease affecting the hip (Legg-Calvé; superior femoral epiphysiolysis)
* Subject who has already undergone surgery on the hip joint
* Subjects with a history of injury to the muscles involved in the assessments within the last year

Where it's running

  • Blanc Gravier sports centers
    Sart Tilman, Liège, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.